How to Read a Peptide COA: HPLC, Mass Spectrometry & Batch Testing Explained

If you’ve ordered a research peptide, chances are a Certificate of Analysis (COA) came with it; a short PDF with a chromatogram, a purity percentage, and a batch number. Most people glance at the purity figure, see something like “≥99%,” and move on without a second thought.

That’s a missed opportunity. A COA actually contains several distinct pieces of information, and understanding what each one measures, and just as importantly, what it doesn’t, is what separates using it as a genuine quality check from simply trusting a number on a page. This guide breaks down what a COA is, how HPLC and mass spectrometry testing actually work, what a purity percentage does and doesn’t tell you, and exactly what to look for before you rely on any batch documentation.

What Is a Certificate of Analysis?

A Certificate of Analysis is a quality-assurance document issued after a sample of material has been independently tested. It records what was tested, which analytical methods were used, and what the results were. Across laboratory and manufacturing settings generally, a COA exists to give the end user a documented, traceable basis for trusting a specific batch of material, rather than simply taking a manufacturer’s word for it.

For research peptides specifically, a COA typically reports two things: purity, established through High-Performance Liquid Chromatography (HPLC), and identity, confirmed through mass spectrometry (MS), both tied to a specific production batch. Every DrPeps order ships with a batch-specific COA, you can view examples on our COA Reports page.

What Is HPLC and What Does It Actually Measure?

High-Performance Liquid Chromatography is an analytical chemistry technique used to separate the individual components of a mixture. A dissolved sample is forced through a column packed with a stationary phase, commonly a C18 reverse-phase material, under high pressure. As the sample travels through the column, different molecules interact with that stationary phase to different degrees, which causes them to move at different speeds and separate from one another.

As each separated component exits the column, it passes through a detector, for peptides, almost always a UV detector reading absorbance around 210–220 nm, the wavelength at which the peptide bond itself absorbs light. Each component produces its own peak on the resulting chromatogram, and the area under each peak is proportional to how much of that component is present. Purity is then calculated by area normalisation: the target peptide’s peak is expressed as a percentage of the total peak area across the entire trace (Creative Proteomics, RP-HPLC Peptide Purity Analysis). If a COA states “≥99% purity by HPLC,” it means the target peptide’s peak accounted for 99% or more of everything the detector picked up.

What a Purity Percentage Does – and Doesn't – Tell You

The remaining percentage isn’t nothing, it represents other detectable material in the vial. Peer-reviewed work on peptide impurity profiling identifies the most common contributors as deletion sequences and truncated chains from incomplete synthesis steps, along with oxidised, degraded, or otherwise chemically modified forms of the target peptide (Separations, 2025). Studies on protein and peptide proteoform characterisation note that impurity types such as truncation and oxidation are specifically difficult to fully resolve using purity data alone, which is exactly why purity and identity are treated as two separate questions in proper analytical practice (Bailey et al., Proteomics, 2024).

In practical terms: a high purity percentage tells you that most of what’s in the vial matches the main peak. It does not, by itself, confirm that the main peak is actually the correct peptide. That second question, identity, not just homogeneity, is what mass spectrometry is for.

What Mass Spectrometry Adds

Mass spectrometry measures the molecular mass of a compound with high precision. Where HPLC establishes how much of a sample is one dominant, uniform component, MS confirms what that component actually is, by matching its measured mass against the expected molecular weight for the target peptide’s sequence. Recent methodological work on synthetic peptide quality control describes MS as the standard tool for verifying both the authenticity and structural integrity of a synthesised peptide, precisely because a clean-looking HPLC trace on its own cannot rule out a synthesis error, a mislabelled batch, or a substituted compound.

This is why HPLC and MS are generally treated as complementary, not interchangeable. Recent analytical work assessing peptide purity by combined mass spectrometry approaches makes the same point: purity assessment and structural/identity confirmation are separate technical challenges that a single method cannot fully resolve on its own (Maroto et al., Methods and Protocols, 2024). A COA built on HPLC purity plus MS identity confirmation is reporting two different, complementary answers, not the same answer twice.

Beyond Purity: Why Endotoxin and Microbial Testing Also Matter

HPLC and MS answer questions about the peptide molecule itself, purity and identity. They say nothing about microbial or bacterial contamination, which is a separate risk introduced during manufacturing, handling, or reconstitution rather than synthesis. This is typically screened for using the Limulus Amebocyte Lysate (LAL) assay, the long-established method for detecting bacterial endotoxin (a component of the outer membrane of gram-negative bacteria), which remains the gold standard for endotoxin detection in research and pharmaceutical settings, because even trace contamination below the level a sterility test would catch can still confound cell-based or in-vivo research.

A comprehensive COA, in other words, is really answering three separate questions, not one: What is this molecule (identity, via MS)? How much of the sample is that molecule (purity, via HPLC)? And is the sample free of biological contamination that could confound results (via endotoxin/microbial testing)? Not every supplier tests for all three, a purity-only COA is common, but it’s a narrower document than one covering all three questions.

Batch-Specific vs. Generic COAs

One distinction worth checking for on any COA: is it tied to the specific batch or lot number of the vial in front of you, or is it a generic document representing “typical” results for the product line as a whole?

A batch-specific COA is issued against one production run and carries a lot number that traces directly back to that run. A generic COA may reflect testing performed on a completely different batch, useful as a general quality indicator, but not proof of what’s actually in the vial you’re holding. For research reproducibility, that distinction matters: it’s what lets you connect any variability observed between experiments back to the actual production lot involved, rather than assuming every vial with the same label is identical.

How DrPeps Tests Every Batch

Every DrPeps batch is independently tested using HPLC and mass spectrometry, and a batch-specific COA is made available with each order, not a generic, product-line-wide document. This pairing reflects the standard described above: not just a purity number, but a documented basis for knowing what a given batch actually contains, tied to the batch itself. You can review sample batch reports on our COA Reports page, and read more about our overall approach to sourcing and testing on our About Us page.

A Practical Checklist: What to Look for on Any Peptide COA

Whichever supplier a COA comes from, a complete one should include:

• Product name and sequence, confirming exactly what the document is certifying

• Molecular weight, matching the theoretical value for the stated peptide

• HPLC purity percentage, with the detection method and wavelength noted

• The chromatogram itself, not just a summary percentage, but the actual trace showing peak separation

• Mass spectrometry data, confirming the expected molecular mass

• A batch or lot number, tying the document to a specific production run

A COA missing several of these, particularly one offering only a purity percentage with no chromatogram, no MS data, and no batch number, provides meaningfully less assurance than one that includes all six.

How to Verify a COA Is Genuine

A document titled “Certificate of Analysis” is only as trustworthy as the process behind it, and a small number of practical checks go a long way toward confirming that:

• Match the batch/lot number on the vial label to the number printed on the COA itself, a mismatch, or no lot number at all, is the single biggest red flag

• Check whether the testing laboratory is named and independently verifiable, a reputable third-party lab will have its own public-facing presence, separate from the seller's website

• Look for a real chromatogram and mass-spectrum image, not just a typed summary of numbers, raw data is far harder to fabricate convincingly than a stated percentage

• Be cautious of a COA that is dated well before your order, reused across many product listings, or otherwise clearly generic rather than batch-specific

None of these checks require a chemistry background, they’re closer to the kind of due diligence you’d apply to any document making a factual claim: does it trace back to a specific, verifiable source, or does it just look official?

Frequently Asked Questions

Can a COA be faked?

In principle, yes! A PDF with a stated purity percentage is trivial to produce regardless of what’s actually in a vial. This is exactly why the checks above matter: a batch-matched lot number, a named and independently verifiable testing laboratory, and raw chromatogram/MS data (not just a summary figure) are all much harder to convincingly fabricate than a number on a page.

Is a lower purity percentage automatically a problem?

Not necessarily, different applications call for different thresholds. Standard in-vitro and bioassay work is often conducted with material in the 98%+ range, while structural studies and receptor-binding work typically call for higher purity, since trace impurities are more likely to confound sensitive measurements. The appropriate threshold depends on the specific research application, not a single universal number.

What’s the practical difference between HPLC and MS on a COA?

HPLC quantifies purity, how much of the sample matches a single dominant, uniform peak. MS confirms identity, that the dominant peak is actually the compound it’s labelled as. A complete COA reports both, because neither answers the other’s question.

Does a COA tell you whether a compound is appropriate for a particular use?

No. A COA is a quality and identity document for the material itself. It doesn’t speak to appropriate use, handling requirements, or legal status in a given jurisdiction, those are separate questions researchers need to satisfy independently.

The Bottom Line

A peptide COA is genuinely useful, but only if you read past the headline purity number. HPLC purity reflects the proportion of a sample matching a single dominant peak; mass spectrometry confirms that peak is the correct compound; and a batch-specific lot number ties both results to the actual vial in front of you. Together, those three elements, not the purity percentage in isolation, are what make a COA a meaningful basis for confidence in a research material. You can explore DrPeps’ full range of independently tested research peptides here, or browse our frequently asked questions for more on how we source and verify every batch.

This article is for educational and research purposes only. DrPeps supplies research-grade peptides intended exclusively for laboratory research and scientific investigation by qualified professionals. Products are not approved for human or veterinary use and are not intended for diagnostic, therapeutic, or clinical applications. See our full Legal Disclaimer (drpeps.com.au/legal) for complete terms.